Data / Top 10 Pharma Companies in Saudi Arabia 2019
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10…
MIDDLE EAST & AFRICA
Morocco Local Production Snapshot
A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Company Spotlight / Iberma
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding…
Saudi Arabia / 5 Things to Know
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…
The Long Read / Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be considered only a middling-size…
The Long Read / The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat…
MEA / The Moroccan Firms Bringing MNCs to Africa
Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of…
Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
In Conversation
Amr El-Neklawy – General Manager Middle East, North & West Africa, Afghanistan & Pakistan, Emcure
Emcure, a fully-integrated Indian pharmaceutical company with a global presence, has invested in Dubai as an operational hub for the Middle East, North and West Africa, Afghanistan and Pakistan. Amr El-Neklawy, Emcure’s general manager for the region, explains how the company’s wide product offering and culture attracted him to the project, his plan to exponentially grow their footprint in the…
Latest Reports
Focus on Egypt
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full…
GE Healthcare Egypt: Reimagining Care Provision
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how…
Read more from Egypt >>
Focus on UAE
The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the…
New UAE Pharma Report April 2020 Out Now
PharmaBoardroom's latest country report gives an up-to-date and comprehensive…
Read more from UAE >>
Focus on Morocco
Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be…
Oncology in Morocco: Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in…
Read more from Morocco >>
Focus on Turkey
Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in…
Acıbadem’s Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more…
Read more from Turkey >>
Hot Topics / Moroccan Pharma
In 2020, PharmaBoardroom has met with stakeholders from across the Moroccan healthcare and life sciences…
Medtech / The UAE: Early Adopters of Cutting-Edge Solutions
In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic…
Hospital Investments in Turkey: Bucking the Trend
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
100 Million Seha: Egypt’s War against Hepatitis C
The 100 Million Seha (100 Million healthy lives) campaign, which kicked off on a national scale in October 2018…
Pharma Faces / Karim Smaira & Kamel Ghammachi of Genpharm
With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at…